Bildkälla: Stockfoto

Medivir: New Early Data from 20 Patients - Redeye

Redeye comments on Medivir's new early positive data from all patients in the study of fostrox + Lenvima in liver cancer.

Redeye comments on Medivir's new early positive data from all patients in the study of fostrox + Lenvima in liver cancer.
Börsvärldens nyhetsbrev
ANNONSER